Compare · ELBM vs TMO
ELBM vs TMO
Side-by-side comparison of Electra Battery Materials Corporation (ELBM) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- ELBM operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $176.13B, about 2557.7x ELBM ($68.9M).
- Over the past year, ELBM is down 33.7% and TMO is up 18.4% - TMO leads by 52.1 points.
- TMO has been more active in the news (19 items in the past 4 weeks vs 6 for ELBM).
- TMO has more recent analyst coverage (25 ratings vs 0 for ELBM).
- Company
- Electra Battery Materials Corporation
- Thermo Fisher Scientific Inc
- Price
- $0.67-9.15%
- $473.94-1.69%
- Market cap
- $68.9M
- $176.13B
- 1M return
- +12.55%
- +2.47%
- 1Y return
- -33.65%
- +18.44%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 6
- 19
- Recent ratings
- 0
- 25
Electra Battery Materials Corporation
Electra Battery Materials Corporation acquires and explores for resource properties in the United States and Canada. It primarily explores for cobalt and silver deposits. The company's flagship project is the Iron Creek cobalt-copper project, which covers an area of approximately 5,900 acres located in Lemhi County, Idaho. It also operates a cobalt refinery for producing battery materials for the electric vehicle supply chain. The company was formerly known as First Cobalt Corp. and changed its name to Electra Battery Materials Corporation in December 2021. Electra Battery Materials Corporation was incorporated in 2011 and is headquartered in Toronto, Canada.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest ELBM
- SEC Form 6-K filed by Electra Battery Materials Corporation
- Amendment: SEC Form SCHEDULE 13G/A filed by Electra Battery Materials Corporation
- Electra Reports Q1 2026 Progress as Refinery Construction Accelerates
- SEC Form 6-K filed by Electra Battery Materials Corporation
- SEC Form 6-K filed by Electra Battery Materials Corporation
- Electra Awards Solvent Extraction Construction Package
- SEC Form 6-K filed by Electra Battery Materials Corporation
- Electra Signs Definitive $20 Million Investment Agreement with Government of Canada to Advance Strategic Refinery
- Amendment: SEC Form SCHEDULE 13G/A filed by Electra Battery Materials Corporation
- SEC Form 6-K filed by Electra Battery Materials Corporation
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)